Drug Information Association (DIA)

𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗶𝗻𝗴 𝗼𝘂𝗿 𝟮𝟬𝟮𝟲 𝗗𝗜𝗔 𝗜𝗻𝘀𝗽𝗶𝗿𝗲 𝗔𝘄𝗮𝗿𝗱 𝗿𝗲𝗰𝗶𝗽𝗶𝗲𝗻𝘁 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗩𝗶𝘀𝗶𝗼𝗻𝗮𝗿𝘆 𝗔𝘄𝗮𝗿𝗱: Noubar Afeyan, PhD, Founder & CEO of Flagship Pioneering! Noubar has fundamentally changed the way breakthrough science is built, from co-founding Moderna to backing bold, unproven ideas that became platform-defining therapies impacting millions worldwide. His vision isn't just ahead of the curve. It is the curve. Join us in celebrating Noubar and all of our 2026 Inspire Award honorees at Celebrate: an unforgettable evening at the DIA 2026 Global Annual Meeting. 📅 June 17 | 6:00–10:00 PM 📍 Philadelphia, PA 🌟 Learn more & register → eu1.hubs.ly/H0vvYnv0 #DIAInspireAwards #GlobalHealth #Biopharma #Moderna #FlagshipPioneering #LifeScience

Big moments of change in an industry create big opportunities for the people who show up. DIA is offering complimentary registration to DIA 2026 Global Annual Meeting in Philadelphia for qualifying professionals currently in career transition from industry or government. If you're figuring out what's next, spending June 14–18 with 4,100 of the most connected people in drug development might be a pretty good place to start. Apply for your complimentary registration here: eu1.hubs.ly/H0vl9C90 #DIA2026 #CareerTransition #Biopharma #OpenToWork #DrugDevelopment

𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 #𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗧𝗿𝗶𝗮𝗹𝘀𝗗𝗮𝘆, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗵𝗮𝘀 𝗻𝗲𝘃𝗲𝗿 𝗹𝗼𝗼𝗸𝗲𝗱 𝗺𝗼𝗿𝗲 𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴. 🌍 Last year at DIA 2025, Craig Lipset, Co-Chair of the Decentralized Trials & Research Alliance, shared what excites him most: accessible trial tools are lowering barriers to drug development, meaning more organizations can now sponsor trials, and more patients, especially those with rare and neglected diseases, gain access to potential treatments. "More therapies being able to move through the pipeline and reach different patient populations in need." That's the promise of modern clinical trials. And it's exactly the kind of conversation happening at #DIA2026, June 14–18 in Philadelphia. 🎥 Watch Craig's full take: eu1.hubs.ly/H0vvWmJ0 🎫 Register for our biggest meeting of the year, #DIA2026: eu1.hubs.ly/H0vvS_d0 #ClinicalResearch #DrugDevelopment #RareDisease #PatientAccess

Incredible momentum at the 2026 DIA China Annual Meeting in Shanghai. 10,000+ attendees and 500+ exhibitors came together for a week of collaboration across biopharma R&D, regulation & healthcare innovation. 12 international regulators. Global industry. Real-time dialogue. Next stop: DIA 2026 Global Annual Meeting in Philadelphia in just a few weeks eu1.hubs.ly/H0vsHdH0 #DIAChina #DIA2026 #ClinicalOperations #LifeSciences

𝟮𝟰 𝗵𝗼𝘂𝗿𝘀 𝗹𝗲𝗳𝘁 before the Call for Abstracts submissions close for the Real-World Evidence Conference happening this Fall! 🚨 This is your final chance to get your work in front of a global audience driving what’s next in life sciences. If you’ve been thinking about it… this is your sign. Hit submit! Don’t miss your moment: eu1.hubs.ly/H0txXcV0 #RWE26 #RealWorldEvidence #RWD #LifeSciences #HealthcareInnovation

If RBQM still feels like a buzzword… this is where it actually clicks. 👇 Join our hands-on short course “𝗙𝗿𝗼𝗺 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗯𝘆 𝗗𝗲𝘀𝗶𝗴𝗻 𝘃𝗶𝗮 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝘁𝗼 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝘁𝗼 𝗥𝗶𝘀𝗸 𝗕𝗮𝘀𝗲𝗱 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁: 𝗛𝗼𝘄 𝗗𝗼𝗲𝘀 𝗶𝘁 𝗧𝗶𝗲 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿?” at #DIA2026. You’ll work inside a real RBQM platform, applying QbD principles, defining CTQs, configuring KRIs, and running central monitoring using simulated study data. From study startup to database lock, you’ll see exactly how ICH E6(R3)/E8(R1) translates into real workflows. What you’ll walk away with: – Practical experience building and executing an RBQM plan – Confidence navigating risk identification, mitigation, and monitoring – Tools to improve data quality, streamline timelines, and support patient safety Perfect for clin ops, data management, central monitoring, and quality leaders ready to level up their RBQM game. 📍 In-person | pre-registration required 💡 Bonus: Register for 2+ short courses and save $50 ✅Secure your spot: eu1.hubs.ly/H0ty5Zk0

Only 𝟭 𝘄𝗲𝗲𝗸 𝗹𝗲𝗳𝘁 to submit your abstract for DIA’s 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲. If you’ve been sitting on insights, data, or a case study… this is your sign to stop overthinking and hit submit. 𝗗𝗘𝗔𝗗𝗟𝗜𝗡𝗘: 𝗔𝗽𝗿𝗶𝗹 𝟮𝟮 𝗦𝘂𝗯𝗺𝗶𝘁 𝗛𝗲𝗿𝗲 👉 eu1.hubs.ly/H0txW6v0 This is where real-world impact meets real conversation, don’t miss your chance to be part of it. #RWE26 #RWE #RWD

Today’s the day. LIFT Series Whale Tank applications close tonight. Big ideas deserve a big stage. Pitch in front of top industry leaders and see where it can take you. Check out the judges in the carousel 👀 Apply now: eu1.hubs.ly/H0tnYT10 #WhaleTank #LIFTSeries #Innovation #PitchDay #DIA2026 #biotech #clintech

Pitch. Validate. Scale. The LIFT Series + Whale Tank at DIA 2026 Global Annual Meeting is a customer-first pitch program for early-stage biotech and clintech companies ready to test their value with the people who matter most. Unlike typical pitch competitions, Whale Tank prioritizes real-world market feedback from customers, strategic partners, regulators, and investors—often leading to meaningful follow-up conversations long after the pitch. If you’re building solutions across therapeutics, diagnostics, discovery, or clinical development, this is your moment to be seen, challenged, and validated live, at DIA’s Global Annual Meeting in Philadelphia this June. 🐋 (Stuffed whales included.) Applications close April 10th! Learn more and apply here: eu1.hubs.ly/H0t2dmx0 #DIA2026 #whaletank #biotech #clintech

Why do people keep coming back to the DIA Global Annual Meeting? The connections. The collaboration. The impact on patients worldwide. Here’s one perspective from our community. 👇 Now we’d love to hear yours. Tell us your #DIAWhy and register by March 12th (this Thursday!) to get your ticket at the Advanced Rate before prices increase! #DIA2026

Calling biotech & clintech founders: the deadline for first wave of pitch applications is closing! We’re reviewing applications from early stage Biotech & Clintech companies for the LIFT Series Whale Tank Pitch Competition. The first wave deadline is February 27th. Applying by this date gives you the best chance to be selected, as there are limited pitch spots available. If you’re building: Novel therapeutics or platform technologies Diagnostics, tools, or software that streamline clinical workflows Digital health or clintech solutions that transform trials or patient care …we want to hear from you. 🏆 Why apply? Exposure to investors and industry leaders High-signal feedback from experienced operators and domain experts Opportunities for follow-on conversations, pilots, and partnerships ⏰ First wave deadline: February 27 (rolling review, limited spots) 📩 Apply now: eu1.hubs.ly/H0s1Gk50 📍 DIA Global Annual Meeting in Philadelphia, PA 📅 Pitch date: June 16 & 17 Tag a founder, scientist, or clinician who should not miss this! #biotech #whaletank #clintech #DIA2026 #pitchcompetition #LIFTSeries

The convergence is here — and it’s accelerating. The DIA 2025 Annual Meeting surfaced a powerful idea from Sahir Ali of ModiVentures: the rise of “non‑biotech bio.” This year, that convergence is no longer theoretical, it’s shaping the companies, technologies, and founders redefining healthcare. At the LIFT Series (our biotech + clintech programming and pitch competition), we’re spotlighting the innovators sitting at the intersection of: - Next‑gen sequencing → biology becomes digital - Large language models → AI that understands biological sequences - Cellular programming → from treatment to cures If you’re building in this space, this is your moment. 👉 Apply to pitch eu1.hubs.ly/H0rFnGD0 👉 Join us in person and be part of the community driving the next wave of curative medicine eu1.hubs.ly/H0rFkZJ0 First round of applications open through February 27th! #LIFTSeries #NonBiotechBio #biotech #whaletank #clintech #DIA2026 #pitchcompetition

AI is no longer theoretical in regulatory review. It’s operational. As agencies like the U.S. Food and Drug Administration integrate AI into scientific and safety evaluations, the global regulatory community is defining what trustworthy, risk-based AI oversight really looks like. At the 2026 DIA Global Annual Meeting in Philadelphia, leaders from FDA, EMA, MHRA, PMDA, ANVISA, Health Canada, and industry will explore: ✔️ How AI is accelerating review timelines while preserving scientific rigor ✔️ Why “human in the loop” remains critical for high-risk decisions ✔️ What risk-based credibility assessment means in practice ✔️ How validation frameworks must address both models and workflows ✔️ The global impact of evolving policy, including the EU AI Act Through initiatives like DIA’s AI Consortium, a neutral, pre-competitive public-private partnership, the life sciences community is moving from guidance to operational reality. If you care about the future of regulatory science, public trust, and responsible AI adoption, this conversation is happening here. Read the article: eu1.hubs.ly/H0rS4Yt0 Then join us in Philadelphia: eu1.hubs.ly/H0rS4cL0 #DIA2026 #LifeScience #AI #Regulatory

🚨 LAST CALL. 🚨 Today is the FINAL day to lock in Early Bird pricing for DIA 2026 Global Annual Meeting! This isn’t the same event you’ve attended before. It’s bigger. Bolder. And built for what’s next. ✨ A redesigned, more dynamic agenda ✨ An elevated exhibit hall experience (hello, The Exchange) ✨ A culminating networking celebration at DIA Celebrate — formerly a Sunday evening event, now moved to Wednesday night and included with standard registration — honoring industry leaders with an open bar and an unforgettable backdrop ✨ Deeper conversations. Stronger connections. Real impact. If you’re serious about advancing your work, expanding your network, and being in the room where the future of our industry is shaped, this is the place to be. At midnight, prices go up. 👉 Secure your spot now before Early Bird disappears. eu1.hubs.ly/H0rJMmZ0 #AnnualMeeting #RegisterNow #EarlyBirdEndsToday

This is more than a meeting, it’s a movement. In 2026, the global life sciences community converges in Philadelphia, as DIA meets America’s 250th anniversary in the city built on bold ideas and collaboration. Connect with innovators, regulators, patient advocates, startups, and industry leaders through: ✨ Daily plenary sessions ✨ LIFT Series biotech and clintech startup pitch competitions & programming ✨ New experiential formats and deep-dive pathways ✨ A citywide celebration you won’t forget Early bird pricing is only available through Thursday February 12th. Join the community shaping the future of global health. eu1.hubs.ly/H0rDLJ70

Join DXC at DIA RSIDM 2026 booth #106 and learn how Regulatory Practitioners can prepare for eCTD 4.0 adoption, growing submission volumes and pressure to modernize with AI. #DXC #Xponential #FirstPoint #RDIM2026 #AutoBuild #AutoCorrect ow.ly/4SQ350Y7vXE

Join DXC at DIA RSIDM 2026 booth #106 and learn how Regulatory Practitioners can prepare for eCTD 4.0 adoption, growing submission volumes and pressure to modernize with AI. #DXC #xponential #firstpoint #rsidm2026 #Simplify #Amplify #Comply ow.ly/4SQ350Y7vXE

Join DXC at DIA RSIDM 2026 booth #106 and learn how Regulatory Practitioners can prepare for eCTD 4.0 adoption, growing submission volumes and pressure to modernize with AI. #DXC #xponential #firstpoint #rsidm2026 #Simplify #Amplify #Comply ow.ly/4SQ350Y7vXE

DIA Conference Jan 26-28 #DIA2026! Visit us at Booth 101! Connect with APCER to advance your PV strategy! Get: • Healthcare expertise • ISO-certified quality • End-to-end accountability in pharmacovigilance

Are you passionate about advancing medical writing and scientific communication? The Call for Abstracts is now open for the DIA Medical Writing & Scientific Communication Conference 2026, taking place 10–11 July in Bengaluru, India. We are accepting abstracts across regulatory writing, publications, patient-centric communication, AI & digitization, real-world evidence, quality, and more. ⏰ Deadline to submit: 31 January. 📣 Notifications: Last week of February. Submit your abstract through the DIA website and be part of the conversation: eu1.hubs.ly/H0r7N3K0.